SageView Advisory Group »

Inhibrx Biosciences shares owned by SageView Advisory Group

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by SageView Advisory Group from 13F filings

Historical chart of SageView Advisory Group investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by SageView Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by SageView Advisory Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.2k 28 79.00

More positions owned by SageView Advisory Group

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Index Fds Extend Mkt Etf (VXF)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Ishares Tr Core Intl Aggr (IAGG)
Ishares Tr Global Reit Etf (REET)
Schwab Strategic Tr Intl Sceqt Etf (SCHC)
Apple (AAPL)
Spdr Series Trust State Street Spd (SPHY)
Ishares Tr National Mun Etf (MUB)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for SageView Advisory Group

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
Sanofi
HighTower Advisors
BlackRock
Susquehanna International
Vanguard Group
Caligan Partners
Sofinnova Ventures
Capital Research Global Investors
State Street Corporation
Millennium Management
Healthcare Of Ontario Pension Plan Trust Fund
Partner Fund Management
Geode Capital Management

View all funds holding Inhibrx Biosciences